Likes
everyday has a new challenging exposure their we will learn about everyday cases alot
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Apollo Hospitals MIS Executive Salary
3 - 7 years exp. (9 salaries) | ₹2.4 L/yr - ₹5.8 L/yr
26%
more | |
Fortis Healthcare MIS Executive Salary
8 - 10 years exp. (4 salaries) | ₹3 L/yr - ₹3.2 L/yr
8%
more | |
Login to view exact salary
| ||
Max Healthcare MIS Executive Salary
2 - 8 years exp. (10 salaries) | ₹3.5 L/yr - ₹5.1 L/yr
29%
more | |
Narayana Health MIS Executive Salary
0 - 4 years exp. (3 salaries) | ₹3.4 L/yr - ₹4.4 L/yr
32%
more | |
Medanta the Medicity MIS Executive Salary
5 - 11 years exp. (4 salaries) | ₹3.4 L/yr - ₹3.5 L/yr
20%
more | |
Wipro MIS Executive Salary
0 - 9 years exp. (338 salaries) | ₹1.2 L/yr - ₹7 L/yr
23%
more | 2 job openings |
Kalintis Healthcare MIS Executive Salary
1 - 7 years exp. (81 salaries) | ₹1 L/yr - ₹3.4 L/yr
22%
less | |
Abbott MIS Executive Salary
2 - 12 years exp. (24 salaries) | ₹2.7 L/yr - ₹5.4 L/yr
30%
more | |
Alkem Laboratories MIS Executive Salary
2 - 21 years exp. (7 salaries) | ₹1.7 L/yr - ₹9.3 L/yr
102%
more | |
Poly Medicure MIS Executive Salary
2 - 3 years exp. (5 salaries) | ₹3.1 L/yr - ₹3.5 L/yr
16%
more | |
GlaxoSmithKline Consumer Healthcare MIS Executive Salary
3 - 9 years exp. (5 salaries) | ₹3.1 L/yr - ₹5.5 L/yr
30%
more | |
Login to view exact salary
| ||
Metropolis Healthcare MIS Executive Salary
0 - 4 years exp. (5 salaries) | ₹2.4 L/yr - ₹6 L/yr
27%
more | |
Sahrudaya Healthcare (Medicover Hospitals) MIS Executive Salary
4 - 8 years exp. (5 salaries) | ₹3.3 L/yr - ₹3.7 L/yr
17%
more | |
Meril MIS Executive Salary
4 - 7 years exp. (4 salaries) | ₹3.3 L/yr - ₹4.5 L/yr
38%
more | |
Sun Pharmaceutical Industries MIS Executive Salary
1 - 5 years exp. (4 salaries) | ₹2.2 L/yr - ₹7.3 L/yr
25%
more | |
IQVIA MIS Executive Salary
2 - 12 years exp. (AmbitionBox Estimate) | ₹2.7 L/yr - ₹3.5 L/yr
8%
more | |
Aurobindo Pharma MIS Executive Salary
5 - 6 years exp. (3 salaries) | ₹3.3 L/yr - ₹6 L/yr
51%
more | |
Top trending discussions